These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study. Greimel A; Habler K; Gräfe C; Maciuga N; Brozat CI; Vogeser M; Zoller M; Happich FL; Liebchen U; Frank S; Paal M; Scharf C Ann Intensive Care; 2023 Nov; 13(1):110. PubMed ID: 37943350 [TBL] [Abstract][Full Text] [Related]
6. Similarities, Differences, and Potential Synergies in the Mechanism of Action of Albumin Dialysis Using the MARS Albumin Dialysis Device and the CytoSorb Hemoperfusion Device in the Treatment of Liver Failure. Dominik A; Stange J Blood Purif; 2021; 50(1):119-128. PubMed ID: 32615564 [TBL] [Abstract][Full Text] [Related]
7. Extracorporeal liver support therapy with Prometheus in patients with liver failure in the intensive care unit. Oppert M; Rademacher S; Petrasch K; Jörres A Ther Apher Dial; 2009 Oct; 13(5):426-30. PubMed ID: 19788460 [TBL] [Abstract][Full Text] [Related]
8. [Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters]. Mitzner S; Klammt S; Stange J; Nöldge-Schomburg GF; Schmidt R Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):199-206. PubMed ID: 15832238 [TBL] [Abstract][Full Text] [Related]
9. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559 [TBL] [Abstract][Full Text] [Related]
10. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Stadlbauer V; Krisper P; Aigner R; Haditsch B; Jung A; Lackner C; Stauber RE Crit Care; 2006; 10(6):R169. PubMed ID: 17156425 [TBL] [Abstract][Full Text] [Related]
11. A comparison among three different apheretic techniques for treatment of hyperbilirubinemia. Viggiano D; de Pascale E; Marinelli G; Pluvio C J Artif Organs; 2018 Mar; 21(1):110-116. PubMed ID: 28887736 [TBL] [Abstract][Full Text] [Related]
12. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial. Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706 [TBL] [Abstract][Full Text] [Related]
13. How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Vienken J; Christmann H Ther Apher Dial; 2006 Apr; 10(2):125-31. PubMed ID: 16684213 [TBL] [Abstract][Full Text] [Related]
14. The Prometheus device for extracorporeal support of combined liver and renal failure. Rifai K; Ernst T; Kretschmer U; Hafer C; Haller H; Manns MP; Fliser D Blood Purif; 2005; 23(4):298-302. PubMed ID: 15980619 [TBL] [Abstract][Full Text] [Related]
15. Liver replacement therapy with extracorporeal blood purification techniques current knowledge and future directions. Papamichalis P; Oikonomou KG; Valsamaki A; Xanthoudaki M; Katsiafylloudis P; Papapostolou E; Skoura AL; Papamichalis M; Karvouniaris M; Koutras A; Vaitsi E; Sarchosi S; Papadogoulas A; Papadopoulos D World J Clin Cases; 2023 Jun; 11(17):3932-3948. PubMed ID: 37388799 [TBL] [Abstract][Full Text] [Related]
17. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386 [TBL] [Abstract][Full Text] [Related]
18. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Di Campli C; Zileri Dal Verme L; Andrisani MC; Armuzzi A; Candelli M; Gaspari R; Gasbarrini A Curr Med Chem; 2003 Feb; 10(4):341-8. PubMed ID: 12570706 [TBL] [Abstract][Full Text] [Related]
19. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure. Oettl K; Stadlbauer V; Krisper P; Stauber RE Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461 [TBL] [Abstract][Full Text] [Related]
20. Prometheus--a new extracorporeal system for the treatment of liver failure. Rifai K; Ernst T; Kretschmer U; Bahr MJ; Schneider A; Hafer C; Haller H; Manns MP; Fliser D J Hepatol; 2003 Dec; 39(6):984-90. PubMed ID: 14642616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]